Palonosetron Impurities are chemical substances that are present in small amounts alongside the active pharmaceutical ingredient (API) in Palonosetron. These impurities can arise during the manufacturing process, storage, or from degradation of the API. It is important to control and monitor the presence of these impurities as they can affect the safety and efficacy of the drug product. Regulatory authorities require strict limits on the levels of impurities in pharmaceutical products.
